Physicians are beginning to question how fair the match program is and whether it meets the needs of doctors-in-training and patients.
Heavy hitters Anthem, HCA and UHS will release their Q2 earnings. Meanwhile, a House panel will delve into the MIPS program.
Browse a list of the nation's 20 largest medical schools--10 allopathic and 10 osteopathic--ranked by total active enrollment for the 2017-18 school year.
House Democrats launched a Medicare for All caucus and its founder says some hospital leaders have been cautiously supportive behind closed doors.
The Pennsylvania Supreme Court reversed a lower court's ruling that UPMC had to cover Highmark Medicare Advantage members in-network through 2019, marking the end of a long-standing feud between the state's largest health system and insurer.
The CMS sent a rule to the White House for review that may resume risk-adjustment payments to insurers. Patient advocates have claimed the agency was trying to sabotage the insurance exchanges by eliminating billions in payments.
LifePoint Health's share price jumped 40% in after-hours trading Friday on news the company is in acquisition talks with a private equity firm.
Nivestym is not the first biosimilar of Neupogen, which helps chemotherapy patients recover, but it reflects the Food and Drug Administration's emphasis on bringing more biosimilars to market.
Armed with comprehensive data, insurers are ramping up their efforts to control costs through population health management.
The maker of a permanent contraceptive implant subject to thousands of injury reports from women and repeated safety restrictions by regulators said Friday that it will stop selling the device in the U.S.
Ascension Medical Group has picked former VA official Dr. Baligh Yehia as the organization's chief medical officer.